Polo-like kinase 1 inhibitors differentiate triple-negative breast cancer towards a luminal cell fate
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP337459
下载链接
链接失效反馈官方服务：
资源简介：
Transcriptomic profiling was applied to investigate the effects of polo-like kinase 1 inhibition in triple-negative breast cancer. Overall design: SUM149PT cells were treated in vitro with rigosertib for 3 days with or without the supplementation of estradiol.
创建时间：
2022-09-03
